{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:48:20Z","timestamp":1782967700987,"version":"3.54.5"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>During the first 2 years of the COVID-19 pandemic, inpatient and ambulatory care declined dramatically. Little is known about prescription drug receipt during this period, particularly for populations with chronic illness and with high risk of adverse COVID-19 outcomes and decreased access to care.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate whether receipt of medications was maintained during the first 2 years of the COVID-19 pandemic among older people with chronic diseases, particularly Asian, Black, and Hispanic populations and people with dementia, who faced pandemic-related care disruptions.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study used a 100% sample of US Medicare fee-for-service administrative data from 2019 to 2021 for community-dwelling beneficiaries aged 65 years or older. Population-based prescription fill rates were compared for 2020 and 2021 vs 2019. Data were analyzed from July 2022 to March 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>The COVID-19 pandemic.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Age- and sex-adjusted monthly prescription fill rates were calculated for 5 groups of medications commonly prescribed for chronic disease : angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins), oral diabetes medications, asthma and chronic obstructive pulmonary disease medications, and antidepressants. Measurements were stratified by race and ethnicity group and dementia diagnosis. Secondary analyses measured changes in the proportion of prescriptions dispensed as a 90-day or greater supply.<\/jats:p><\/jats:sec>Results<\/jats:title>Overall, the mean monthly cohort included 18\u202f113\u202f000 beneficiaries (mean [SD] age, 74.5 [7.4] years; 10\u202f520\u202f000 females [58.1%]; 587\u202f000 Asian [3.2%], 1\u202f069\u202f000 Black [5.9%], 905\u202f000 Hispanic [5.0%], and 14\u202f929\u202f000 White [82.4%]); 1\u202f970\u202f000 individuals (10.9%) were diagnosed with dementia. Across 5 drug classifications, mean fill rates increased by 2.07% (95% CI, 2.01% to 2.12%) in 2020 and decreased by 2.61% (95% CI, \u22122.67% to \u22122.56%) in 2021 compared with 2019. Fill rates decreased by less than the mean overall decrease for Black enrollees (\u22121.42%; 95% CI, \u22121.64% to \u22121.20%) and Asian enrollees (\u22121.05%; 95% CI, \u22121.36% to \u22120.77%) and people diagnosed with dementia (\u22120.38%; 95% CI, \u22120.54% to \u22120.23%). The proportion of fills dispensed as 90-day or greater supplies increased during the pandemic for all groups, with an increase per 100 fills of 3.98 fills (95% CI, 3.94 to 4.03 fills) overall.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This study found that, in contrast to in-person health services, receipt of medications for chronic conditions was relatively stable in the first 2 years of the COVID-19 pandemic overall, across racial and ethnic groups, and for community-dwelling patients with dementia. This finding of stability may hold lessons for other outpatient services during the next pandemic.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.13919","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T15:04:42Z","timestamp":1684335882000},"page":"e2313919","source":"Crossref","is-referenced-by-count":10,"title":["Receipt of Medications for Chronic Disease During the First 2 Years of the COVID-19 Pandemic Among Enrollees in Fee-for-Service Medicare"],"prefix":"10.1001","volume":"6","author":[{"given":"Nancy E.","family":"Morden","sequence":"first","affiliation":[{"name":"The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire"},{"name":"UnitedHealthcare, Minnetonka, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Obermeyer","sequence":"additional","affiliation":[{"name":"School of Public Health, University of California, Berkeley"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Skinner","sequence":"additional","affiliation":[{"name":"UnitedHealthcare, Minnetonka, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"issue":"1","key":"zoi230427r1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7326\/M20-3026","article-title":"Reduced in-person and increased telehealth outpatient visits during the COVID-19 pandemic.","volume":"174","author":"Baum","year":"2021","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi230427r2","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1377\/hlthaff.2020.00980","article-title":"The impact of the COVID-19 pandemic on hospital admissions in the United States.","volume":"39","author":"Birkmeyer","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"zoi230427r3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/MLR.0000000000001747","article-title":"The impact of the COVID-19 pandemic on health care utilization among insured individuals with common chronic conditions.","volume":"60","author":"Kim","year":"2022","journal-title":"Med Care"},{"issue":"4","key":"zoi230427r4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249453","article-title":"Patient access to chronic medications during the COVID-19 pandemic: evidence from a comprehensive dataset of US insurance claims.","volume":"16","author":"Clement","year":"2021","journal-title":"PLoS One"},{"key":"zoi230427r5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.600385","article-title":"Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) are protective against ICU admission and mortality for patients with COVID-19 disease.","volume":"8","author":"ElAbd","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"zoi230427r6","doi-asserted-by":"publisher","first-page":"l2238","DOI":"10.1136\/bmj.l2238","article-title":"Clinical guidelines on antidepressant withdrawal urgently need updating.","volume":"365","author":"Davies","year":"2019","journal-title":"BMJ"},{"issue":"11","key":"zoi230427r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.15111","article-title":"Association between a temporary reduction in access to health care and long-term changes in hypertension control among veterans after a natural disaster.","volume":"2","author":"Baum","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi230427r9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M20-6306","article-title":"Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review.","volume":"174","author":"Mackey","year":"2021","journal-title":"Ann Intern Med"},{"issue":"39","key":"zoi230427r10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101386118","article-title":"Excess mortality from COVID and non-COVID causes in minority populations.","volume":"118","author":"Cronin","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"zoi230427r11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamaneurol.2022.0010","article-title":"Trends in mortality rates among Medicare enrollees with Alzheimer disease and related dementias before and during the early phase of the COVID-19 pandemic.","volume":"79","author":"Gilstrap","year":"2022","journal-title":"JAMA Neurol"},{"issue":"2","key":"zoi230427r12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/14713012211053971","article-title":"Exploring the impact of COVID-19 on the care and quality of life of people with dementia and their carers: a scoping review.","volume":"21","author":"Masterson-Algar","year":"2022","journal-title":"Dementia"},{"issue":"4","key":"zoi230427r16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1214\/13-STS453","article-title":"Standardization and control for confounding in observational studies: a historical perspective.","volume":"29","author":"Keiding","year":"2014","journal-title":"Stat Sci"},{"issue":"6","key":"zoi230427r17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1377\/hlthaff.2021.00118","article-title":"Growth in Medicare Advantage greatest among Black and Hispanic enrollees.","volume":"40","author":"Meyers","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"zoi230427r18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.v17.3","article-title":"2021 Alzheimer\u2019s disease facts and figures.","volume":"17","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"6","key":"zoi230427r19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.amjmed.2019.12.021","article-title":"Medication adherence, health care utilization, and spending among privately insured adults with chronic conditions in the United States, 2010-2016.","volume":"133","author":"Gillespie","year":"2020","journal-title":"Am J Med"},{"issue":"3","key":"zoi230427r20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.amjopharm.2012.04.002","article-title":"Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.","volume":"10","author":"Simoni-Wastila","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"12","key":"zoi230427r23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.18553\/jmcp.2014.20.12.1193","article-title":"Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.","volume":"20","author":"Leslie","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"zoi230427r25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/dc07-1924","article-title":"Medication adherence and racial differences in A1C control.","volume":"31","author":"Adams","year":"2008","journal-title":"Diabetes Care"},{"key":"zoi230427r26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjcard.2021.08.070","article-title":"Gaps and disparities in primary prevention statin prescription during outpatient care.","volume":"161","author":"Metser","year":"2021","journal-title":"Am J Cardiol"},{"issue":"24","key":"zoi230427r27","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.jacc.2021.06.017","article-title":"Race, ethnicity, hypertension, and heart disease: JACC Focus Seminar 1\/9.","volume":"78","author":"Ogunniyi","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"zoi230427r29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jamaoncol.2022.5481","article-title":"Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic.","volume":"9","author":"Oakes","year":"2023","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi230427r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6147","article-title":"Prescribing of opioid analgesics and buprenorphine for opioid use disorder during the COVID-19 pandemic.","volume":"4","author":"Currie","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi230427r32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00125-022-05833-z","article-title":"Diabetes and the COVID-19 pandemic.","volume":"66","author":"Khunti","year":"2023","journal-title":"Diabetologia"},{"key":"zoi230427r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111946","article-title":"Evolution of physical function, cognition, depressive mood, and quality of life during the COVID-19 pandemic in prefrail elderly people: a longitudinal cohort study (Covid-Mefap).","volume":"168","author":"Castell-Alcal\u00e1","year":"2022","journal-title":"Exp Gerontol"},{"issue":"17","key":"zoi230427r34","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.3390\/ijerph191710913","article-title":"Predictive Factors of anxiety, depression, and health-related quality of life in community-dwelling and institutionalized elderly during the COVID-19 pandemic.","volume":"19","author":"Pascut","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"zoi230427r35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11883-022-01032-8","article-title":"Long-term cardiovascular effects of COVID-19: emerging data relevant to the cardiovascular clinician.","volume":"24","author":"Tobler","year":"2022","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"zoi230427r36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mayocp.2022.09.005","article-title":"Characteristics, treatment patterns, and clinical outcomes after heart failure hospitalizations during the COVID-19 pandemic, March to October 2020.","volume":"98","author":"Yousufuddin","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"zoi230427r24"},{"key":"zoi230427r8","unstructured":"Chandra? A, Flack? E, Obermeyer? Z. The health costs of cost-sharing: working paper 28439. National Bureau of Economic Research. Accessed April 11, 2023. https:\/\/www.nber.org\/system\/files\/working_papers\/w28439\/w28439.pdf"},{"key":"zoi230427r13","unstructured":"Research Data Assistance Center. Research Triangle Institute (RTI) race code. Accessed November 11, 2022. https:\/\/resdac.org\/cms-data\/variables\/research-triangle-institute-rti-race-code"},{"key":"zoi230427r14","unstructured":"First Databank. FDB MedKnowledge. Accessed December 9, 2022. https:\/\/www.fdbhealth.com\/solutions\/medknowledge-drug-database"},{"key":"zoi230427r15","unstructured":"Research Data Assistance Center. Part D event (PDE) file. Accessed November 11, 2022. https:\/\/resdac.org\/cms-data\/files\/pde"},{"key":"zoi230427r21","unstructured":"Centers for Medicare & Medicaid Services. Part C and D performance data. Accessed November 19, 2022. https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovGenIn\/PerformanceData"},{"key":"zoi230427r22","unstructured":"Cubanski? J, Fuglesten Biniek? J, Rae? M, Damico? A, Frederiksen? B, Salganicoff? A. Mail Delays could affect mail-order prescriptions for millions of Medicare Part D and large employer plan enrollees. Kaiser Family Foundation. Accessed November 20, 2022. https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/mail-delays-could-affect-mail-order-prescriptions-for-millions-of-medicare-part-d-and-large-employer-plan-enrollees\/"},{"key":"zoi230427r28","unstructured":"Centers for Medicare & Medicaid Services. Medicare telemedicine health care provider fact sheet. Accessed November 20, 2022. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/medicare-telemedicine-health-care-provider-fact-sheet"},{"key":"zoi230427r30","unstructured":"Drug Enforcement Administration Diversion Control Division. COVID-19 information page. Accessed November 20, 2022. https:\/\/www.deadiversion.usdoj.gov\/coronavirus.html"},{"key":"zoi230427r37","doi-asserted-by":"crossref","unstructured":"Feng? J, Higgins? MJ, Patel? E. All children left behind: drug adherence and the COVID-19 pandemic. 2023. Accessed March 25, 2023. https:\/\/www.nber.org\/system\/files\/working_papers\/w30968\/w30968.pdf","DOI":"10.3386\/w30968"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805002\/morden_2023_oi_230427_1683726836.35543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T15:04:47Z","timestamp":1684335887000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.13919","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]}}}